http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200038339-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8578aa45d64b691f872d3436a2f4f0a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate | 2016-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf70f834b5de7cd02abf722129036d5c |
| publicationDate | 2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20200038339-A |
| titleOfInvention | Multivalent vlp conjugates |
| abstract | The present invention relates to a vaccine comprising a capsule polysaccharide conjugated with one or more components of virus-like particles (VLPs), and a method of administering and manufacturing a vaccine of the present invention. Preferably, the vaccine of the invention constructs a therapeutically effective response to multiple strains and / or serotypes of the same or different infectious agents in the individual in need. Preferably, the vaccine described above constructs a therapeutically effective response to all pathogenic strains and / or serotypes of the same infectious agent. In particular, the present invention relates to methods and compositions for cost-effectively administering a vaccine to a patient in need of administration of the vaccine, the efficacy of exposing a patient's immune system to only immunogenic components that may be beneficial in establishing a prophylactic immune response. And safety are both increased and cost effective. |
| priorityDate | 2015-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.